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Stlmmary 
Mice homozygous for the Ipr gene have a defect inJ~s (CD95), a cell surface receptor that belongs 
to the tumor necrosis factor receptor family and that mediates apoptosis. This genetic abnormality 
results in lymphoproliferation characterized by the accumulation of CD4- CDS- (double nega- 
tive [DN]) T cells, autoantibody production, and background strain-dependent, end-organ disease. 
Our previous results suggested that major histocompatibility  complex (MHC) class I may be 
involved in the development of DN cells. To test this hypothesis, we derived C57BL/6-1pr/Ipr 
(B6/Ipr) mice that were deficient for the 32-microglobulin gene (32m-lpr)  and had no detectable 
class I expression. At 6 mo of age, compared with B6/lpr littermates with normal class I genes, 
these mice showed greatly reduced lymphadenopathy,  mostly due to a dramatic decrease in the 
number of DN cells. Significant changes in the percentage of other T cell subsets were noted, 
but only "y/~+ T  cells showed a marked increase in both percentage and absolute numbers. 
Analysis of T cell receptor V3 expression of the remaining DN T cells in 32m- Ipr mice showed 
a shift to a CD4-1ike repertoire from a CDS-like repertoire in control B6/Ipr mice, indicating 
that a small MHC class II selected DN population was unmasked in lpr mice lacking class I. 
We also found that the production of immunoglobulin G (IgG) autoantibodies (antichromatin 
and anti-single stranded DNA), total IgG and IgG2a, but not total IgM or IgM rheumatoid 
factor, was significantly reduced in the fl2m-lpr mice. This work suggests that >90% of DN 
T cells in lpr mice are derived from the CD8 lineage and are selected on class I. However, a 
T cell subset selected on class II and T cells expressing 3'/~ are also affected by the lpr defect 
and become minor components of the aberrant DN population. 
T 
he lpr routine model is characterized by autoantibody 
production, strain-dependent,  end-organ autoimmune 
disease, and severe lymphadenopathy (1). The bulk of the 
lymphadenopathy is accounted for by the accumulation of 
TCR c~//$  + T cells that are CD4- and CDS- (double nega- 
tive [DN])  1 and aberrantly express other markers  such as 
B220. Recent work has demonstrated that the lpr defect is 
due to a transposon disrupting the gene coding for Fas (CD95), 
a cell surface  receptor that belongs to the TNF-receptor family 
and that is found on activated  lymphocytes (2) and other tissues 
(3). Cross-linking  by Fas ligand or by antibodies to Fas in- 
duces apoptosis in cells expressing this receptor (4-9). 
1 Abbreviations used in this paper: B2m, B2-microglobulin; DN,  double 
negative; ss, single stranded. 
This paper was presented at the Annual Meeting of the American College 
of Rheumatology in Minneapolis, MN on 24 October 1994. 
The derivation of the DN T cells in Ipr mice and the reason 
they develop in the setting of defective expression of  f as is 
mostly unknown. Previous studies demonstrated that these 
cells undergo negative selection during intrathymic develop- 
ment, despite the markedly decreased expression of Fas in 
the lpr thymus (10-12). These studies also suggested that the 
DN T cells are derived from thymic precursors that express 
CD4 and CD8, a conclusion supported by the the methyl- 
ation pattern of the CD8 gene in these cells (13). Other studies 
have indicated that the DN T cells proliferate predominantly 
in the periphery (11, 14-16). It has been postulated that DN 
T cells may represent autoreactive cells that cannot be deleted 
secondary to theirj~s defect; this may explain their possible 
role in the autoimmune process (17). Mature CD4 § T cells 
from MRL-lpr/lpr  mice have been shown to be resistant to 
anti-CD3 or antigen-mediated  apoptosis (18, 19) and peripheral 
CD8 + cells appear to be resistant to superantigen-mediated 
deletion (20). Whether the cells that fail to undergo apop- 
tosis subsequently downregulate CD4 or CD8 and become 
DN is unknown. 
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repertoire of DN T  cells demonstrated a pattern similar to 
that of CD8 + T  cells (11).  When comparisons were made 
to determine the influence of different class I and II MHC 
molecules on T cell repertoire formation, the results suggested 
that DN T  cells in lpr mice may be selected on class I MHC 
molecules. Selection on MHC class II could not be demon- 
strated. In the present studies, we have extended these obser- 
vations  by  studying  Ipr  mice  lacking  ~/2-microglobulin 
(~2m-).  These  mice  have  deficient  expression  of class  I 
MHC  molecules, which  mostly prevents the development 
of the CD8 + T  cell subset (21).  Compared with lpr ~2m + 
littermates, ~2m- Ipr mice showed a dramatic decrease in ab- 
solute numbers and percentages of CD8 + and DN T  cells, 
and consequently greatly reduced lymphadenopathy.  Anal- 
ysis of the remaining DN  T  cells showed that  their TCR 
V~ repertoire resembled that of CD4 + cells, suggesting se- 
lection on MHC class II. We also noted a significant decrease 
in IgG, but not IgM,  total immunoglobulin  and autoanti- 
body levels in these knockout  mice. 
Materials and Methods 
Mice.  Mice with the ~zm gene disrupted (/~2m-)  and back- 
crossed six generations to the C57BL/6 (B6) strain were kindly 
provided by Beverly Koller (University of North Carolina at Chapel 
Hill (22, 23). We backcrossed these mice twice to B6-1pr/Ipr mice 
originally obtained from The Jackson Laboratory (Bar Harbor, ME). 
Individual mice genotyped as homozygous foe lpr and heterozy- 
gous for the ~2m knockout were interbred to generate lpr/Ipr mice 
deficient for the ~2m gene (~2m-Ipr)  and 1pr/lpr littermate con- 
trols homozygous for the ~2m wild-type gene (~2m+l/,r). B2m and 
Ipr phenotypes were confirmed by lack of expression of MHC class 
I antigens, as determined by cell surface staining and cytofluoro- 
graphic analysis, and the accumulation of Thyl.2 +B220 + T cells, 
respectively. Mice were maintained at the University of North Caro- 
lina School of Medicine animal facility. 
Genotyping.  Genomic  DNA  was  prepared  from  tails.  Oli- 
gonudeotide primers for the B2m- gene were located at the 5' and 
the 3' ends of the disrupted ~2m exon II and the 3' end of the 
inserted Neo gene (~2m5': GTG GCC CTC AGA AAC CCC TC; 
B2m3': AGA CGG TCT TGG GCT CGG CC; and Neo3': ACG 
GTA TCG CCG CTC CCG AT, respectively;  22).  Oligonucleo- 
tide primers for lpr locus were designed based  on the published 
nucleotide sequence for the insertion of the early transposable  ele- 
ment (ETn) into intron II of theJ~s gene in Ipr mice (2). Primers 
were located 5' to the ETn insertion site, 3' to the ETn insertion 
site, and in the 5' end of the ETn (FAS5': CAA GCC GTG CCC 
TAG GAA ACA CAG; FASY: GCA GAG ATG CTA AGC AGC 
AGC CGG; and ETNY: GTG GAG CTC CAA TGC AGC GTT 
CCT, respectively). Amplifications were performed in separate three- 
primer 50-/~1 PCR reactions under standard conditions with 1.0 
mM  MgC12 using  Amplitaq  DNA  polymerase  (Perkin-Elmer 
Cetus, Norwalk, CT). Amplification was performed for 30 cycles 
with temperatures of 94~  melting, 55~  annealing,  and 72~ 
extension. PCR products were separated on a 1% agarose gel and 
visualized by ethidium bromide staining.  Using the three primers 
mentioned above, the ~2m- three-primer PCR generated products 
of 284 and 200 bp for the wild-type and knockout genes, respec- 
tively. Similarly,  the lpr three-primer PCR generated products of 
240 and 445 bp for the wild-typefis and mutant Ipr genes, respec- 
tively. This permitted the detection of the heterozygous and both 
homozygous states utilizing a single PCR reaction for each gene. 
Preparation of Cells.  At 6 mo of age, mice were killed, and cer- 
vical, axillary, scapular, femoral, mesenteric,  periaortic, and supra- 
renal LNs and spleens were removed and weighed. Single-cell sus- 
pensions  of all LN and spleen cells were made by passing  them 
through a mesh screen in cold medium (ILPMI 1640 with 15 mM 
Hepes, 5% FCS [Hyclone Laboratories,  Logan, UT],  100 U/ml 
penicillin, and 100 #g/ml streptomycin from the University of North 
Carolina Cancer Center, and 5  x  10 -s M 2-ME [Sigma Chem- 
ical Co., St. Louis, MO]). RBC were lysed with NH4C1, and cells 
were washed twice before counting by an automated cell counter. 
For experiments analyzing expression  of VB chains,  lymph node 
T  cells were first prepared by nylon wool purification (10). 
Antibodies.  Antibodies used for immunofluorescence staining 
included:  anti-IgM  b (AF6-78-FITC,  mouse IgG1;  PharMingen, 
Inc., San Diego, CA), anti-FcRIII (CD16) (2.4G2, rat IgG1) (24), 
anti-CD45R/B220 (RA3-6B2-BNHS, rat IgG2a; PharMingen), 
anti-H-2D b (28-14-8S, mouse IgG2a; courtesy of  Jeffrey Frelinger, 
University of North Carolina at Chapel Hill, Chapel Hill, NC) 
(25),  and anti-mouse IgG2a (goat polyclonal-FITC; Boehringer 
Mannheim, Indianapolis,  IN). Anti-CD4. anti-CD8, anti-Thyl.2, 
and mouse anti-rat ~ light chain were previously described  (26, 
27).  The mAb to CD4,  CD8, and TCR V/~ chains  used in the 
V~ repertoire studies  were previously described  (11). 
Immunofluorescence Staining and Flow Cytometry.  In 96-well mi- 
crotiter plates,  1.5  x  106 cells were stained  in cold media con- 
taining 3% FCS and 0.1% NAN3. In general, antibodies were in- 
cubated with cells on ice for 30 min. Streptavidin-R-phycoerythrin 
(Southern Biotechnology Associates, Birmingham, AL) was used 
as a second reagent. Cell surface immunofluorescence analysis of 
LN and spleen cells was performed by single- and two-color flow 
cytometry analysis of at  least  104 events  for each  sample  on a 
FACScan  |  (Becton Dickinson & Co., Mountain View, CA) with 
Cytomation data acquisition and software (Fort Collins, CO) with 
size gating on the lymphocyte population. 
Two-color immunofluorescence was used to analyze TCR V~ 
expression separately in the CD4 +, CD8 +, CD4-CD8-  (analyzed 
by costaining with both fluoresceinated  anti-CD4 and CD8 anti- 
bodies), and B220 § T cell populations as described (11). In initial 
experiments, results  for DN cells and B220 § T  cell were virtu- 
ally identical, and therefore data are only presented for DN cells. 
Cell stainings with anti-V~ mAb and their analysis were performed 
as described (11). 
Quantification  of Immunoglobulin  and  Autoantibodies Levels by 
ELISA.  Mice were bled monthly from 3 to 6 mo of age. Serum 
samples were assayed in duplicate for total IgG, IgG2a, and IgM 
levels, as well as IgG antichromatin, IgG anti-single stranded (ss) 
DNA, and IgM RF anti-IgG2b  b activity, as previously described 
(28, 29). Results for antichromatin and anti-ssDNA antibodies are 
reported in equivalent dilution factors (EDF) of standardized refer- 
ence MRL/Ipr  sera as previously defined by the formula: EDF  = 
(dilution of standard reference sera which gives the equivalent OD 
of the test serum)  x  106 (30). 
Statistics.  Student's t-test was used to determine the statistical 
significance  of differences between groups. 
Results 
Decreased  Lymphadenopathy  in fl2m-lpr  Mice.  Lpr  (i.e., 
Ipr/Ipr)  mice genotyped as homozygous for the B2m-knock- 
out locus  (Bzm-lpr) and lpr littermates  carrying wild-type 
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Figure  1.  Weights  and  total  cell  numbers  for  LNs  and  spleens  in 
32m-lpr (I)  (n  =  10),  32m+lpr (~)  (n  =  12),  and C57BL/6  (!1)  (n 
=  6). Data (mean _+ SE) are shown for mice killed at 6 mo of age. Statistical 
comparisons are to the 32m-lpr group: (ns) not  significant using p  = 
0.05 as a cutoff, (*) p ~<0.05 and (**) p <0.005. 
32m genes (32m + Ipr) were followed for the development of 
lymphoproliferation  and autoimmunity.  None of the mice 
showed evidence of obvious clinical disease or infection during 
the first 6 mo of life.  Both groups  of mice were killed at 
6 mo of age, and LNs and spleens were removed and weighed. 
The lack of expression of class I MHC in 32m- Ipr mice was 
confirmed by cell surface staining of LN and spleen cells with 
an  anti-H-2D b  reagent.  Cytofluorographic  patterns  for 
32m-lpr cells were indistinguishable  from the background 
staining of control cells  from MP,  L  (H-2  k) mice (data not 
shown).  As shown in Fig.  1,  the 32m-lpr mice showed a 
marked decrease in lymphadenopathy compared with the con- 
trol group. This difference reflected a fourfold decrease in total 
LN cell numbers in the 32m-lpr group compared with con- 
trols. Compared with non-lpr B6 mice, however, the LN cell 
numbers in the 32m 7 IFr group were still increased sevenfold. 
Fig.  1 also shows that  spleen weights and cell numbers in 
32m-lpr  mice  were only  slightly  reduced,  and  that  these 
differences were not  significant. 
Reduced Accumulation of DN  T  Cells in ~2m-lpr Mice. 
Similar to 32m-knockout mice that do not carry the Ipr mu- 
tation,  32m-lpr mice showed the expected decrease in the 
percentage and number  of CD8 + cells  (Fig.  2, A  and B). 
Importantly,  32m-lpr  mice  also  demonstrated  a  marked 
reduction in the percentage and number of aberrant DN T 
cells, best identified as the Thyl.2 +  CD4-CD8-  subset. The 
difference  between  the  Thyl.2+CD4-CD8 -  and  the 
Thyl.2+B220 + subset was due to the inclusion of the CD4 + 
B220 +  subsets  in  the  latter  population  (data  not  shown) 
(31).  Whereas DN T  cells accounted for 50-70%  of total 
LN  cells  in  32m-lpr  mice,  this  percentage  decreased  to 
<20%  in 32m-Ipr.  Coupled with the decrease in total cell 
numbers,  this resulted in a 90% decrease in the number of 
DN cells  in the 32m-Ipr group  (Fig.  2 B). 
Nearly all DN T cells in the 32m + Ipr mice expressed the 
or~3 TCR (Fig.  3).  However, TCR or~3 + cells  accounted 
for only 55% of the DN T  cells in 32m-lpr mice (Fig.  3). 
The remaining  DN T  cells expressed TCR ',(/8 receptors, 
which meant  a 30-fold increase in the percentage of TCR 
3'/8 in 32m-Ipr DN cells compared with controls. Despite 
the decrease in total T  cells in 32m-lpr mice,  the absolute 
number of "y/8 + ceils was actually increased in these mice 
(22  _+  1.4  x  106 vs.  11  -+  3.3  x  106,  p  <(0.005). 
The  reduction  in  DN  cells and loss  of CD8 ÷ cells  ac- 
counted for a significant increase in the percentage of CD4 ÷ 
cells  in the 32m-lpr group when compared with controls 
(iv  =  0.001).  However, because of the reduced total T  cell 
numbers,  this  difference in  percentage  did not  result  in  a 
significant increase in total CD4 + cells numbers (Fig.  2 B). 
The CD4 + analysis included both the CD4 ÷ B220- and the 
abnormal CD4+B220 + subsets found in Ipr mice. Separate 
experiments  staining  for this latter  population  showed no 
difference between the 32m- Ipr and 32m ÷ Ipr mice (data not 
shown). 
Changes in  TCR  Vl? Repertoire of Residual DN Cells in 
~2m-lpr Mice.  We compared  the  TCK V3 repertoire  of 
DN T  cells  to that  expressed by CD4 + and CD8 + single 
positive cells in 32m-lpr and 32m + lpr mice. The repertoire 
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Figure  2.  Percentage (A) and total cell 
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Figure  3.  Percentage of DN cells expressing CD3, TCR o~/fl, or TCR 
3'/8 in fl2m  lpr (I)  (n  =  7) and fl2m*lpr  (p)  (n  =  7) mice (mean  _+ 
SE). LN cells from 6-mo-old mice were purified over nylon wool columns 
before staining for CD4, CD8, and the respective  TCR marker. (*) p ~<0.05 
and (**) p  <0.005. 
of the CD4 ÷ cells was remarkably similar in the two groups 
of mice (Fig.  4 A).  Because of the very low percentage of 
CD8 + cells in fl2m-  mice,  the CD8 + repertoire was  ana- 
lyzed only in fl2m + Ipr mice. The results of the CD4 + and 
CD8 + repertoires in these experiments were similar to our 
previous reports (11). Particular differences in Vfl expression 
between the CD4 ÷ and CD8 ÷ populations should be em- 
phasized.  For example,  the percentage of Vfl5 ÷ cells  was 
significantly greater in the CD8 + population, whereas the 
opposite was true for Vf114 expression. These differences reflect 
the relative selection of CD8 + cells on MHC class I in B6 
(i.e.,  H-2  b) mice (32,  33). 
The DN  cells from the fl2m-lpr group showed a TCR 
Vfl usage pattern distinct from that of the fl2m +Ipr group 
(Fig. 4 B). As previously observed in B6-Ipr/Ipr  mice, the reper- 
toire of the fi2m +Ipr DN  cells  was  similar  to  that  of the 
CD8 + subset.  Remarkably, TCR Vfl expression  of DN cells 
in fl2m-lpr mice shifted to a pattern  that resembled more 
the CD4 + subset (compare Fig.  4, A  and B). In particular, 
the significant decrease  in Vfl5 and increase  in Vf114 usage 
by fl2m-lpr  DN cells distinguished them from DN T  cells 
in fl2m + Ipr and paralleled  the CD4 + cells from both groups. 
Previous studies from our laboratories have also demon- 
strated an increased percentage of DN Vf18.3 + cells, out of 
proportion to levels in  the  CD4 +  or CD8 +  subsets  (11). 
This selective expansion of DN Vf18.3 + T cells was also ap- 
parent in fl2m + Ipr mice (Fig. 4 B). Thus, the percentage ex- 
pressing Vf18.3 in the DN T cell population was 20 vs. 8.7% 
of CD4 + cells and 8.2% of CD8 + cells in the control group 
(iv  <0.001  for both  groups).  However this  expansion  of 
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Figure  4.  TC1K Vfl repertoire in fl2m  lpr compared with fl2m + Ipr. 
LN cells were purified over nylon wool columns before staining for different 
Vfis and CD4, CD8, or CD4 and CD8.  Results are shown for the mean 
percentage (+_ SE) of CD4 or CD8 cells (A) and of DN cells in (B) (4-11 
different mice in each group were analyzed for each Vfl).  Because of the 
low percentage of CD8 + cells  in fl2m-lpr mice (see  Fig.  2),  the reper- 
toire of this population could not be reliably determined. Values for the 
CD8 population for Vfl3 and Vfl6 were determined in a separate group 
of age-matched B6-1pr/lpr  mice. Statistical comparisons shown are between 
CD4-fi2m-  or CD4-fl2m ÷ and CD8-fl2m + subsets in (A)and between 
DN subsets for Vfl5, 8.3, and 14 in (B): (*)p <0.005.  Statistical analysis 
was  not  performed  for the other Vfl subsets. 
Vf18.3 + DN cells was no longer apparent in fl2m-[pr mice 
(11%  in DN cells). 
Decreased Total IgG  and  IgG  Autoantibodies Levels in 
fl2m-lpr  Mice.  We  also  determined  the  effect  of class  I 
deficiency on autoantibody production and total Ig levels. Fig. 
5 A  shows  the increased production of IgG antichromatin 
in fl2m+Ipr mice,  which  is  markedly reduced in fl2m-lpr 
mice. Similarly, fl2m-Ipr mice produced much less IgG anti- 
ssDNA with age than controls (Fig.  5 B). In contrast, IgM 
RF anti-IgG2b  b activity levels were equally elevated at 3 mo 
of age and increased at the same rate in both groups (Fig. 
5 C). fl2m ÷ lpr mice showed the expected age-dependent in- 
crease in total IgG2a (Fig.  5 D), total IgG (Fig.  5 E),  and 
total IgM levels (Fig.  5 F).  Interestingly, the levels in the 
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Figure  5.  Autoantibodies and 
total Ig  levels for ~2m-lpr (I) 
(n =  16) and [32m+lpr (Q) (n = 
15) mice. Results (mean _+ SE) are 
shown for IgG antichromatin (.4), 
IgG anti-ssDNA (B), IgM RF anti- 
IgG2b  b (C), total IgG2a (D) total 
IgG (E), and total lgM (F). (EDF) 
Equivalent dilution factors  as defined 
in Materials and Methods. (us)  Not 
significant using iv  =  0.05 as a 
cutoff, (*) p  <0.05 and  (**)  p 
<0.005. 
/32m-lpr  mice paralleled  the pattern  seen  in  the  autoanti- 
bodies with significantly  lower total IgG and total IgG2a levels 
but no difference in the  total IgM levels. 
In contrast  to MRL/Ipr  mice, B6/Ipr mice demonstrate 
minimal glomerular pathology (34 and our unpublished data). 
Kidneys from two/32m-Ipr  mice were examined by light 
microscopy for pathologic abnormalities.  Not surprisingly, 
especially considering the decreased IgG autoantibody levels 
in  these mice,  no abnormalities  were noted. 
Discussion 
The current studies were undertaken to understand better 
the derivation ofDN T cells in Ipr mice. The results demon- 
strate that the accumulation of aberrant DN cells is mostly 
abrogated in Ipr mice deficient in B2m expression. However, 
the reduction in lymphoproliferation in these mice also un- 
masked a minor TCR ot/~/+  DN  subset with  a repertoire 
similar  to  that  of the CD4 + population  as well as an  ex- 
panded DN population expressing 3'/8 TCR. We also noted 
that lpr mice carrying the B2m knockout gene had decreased 
levels of total IgG and IgG autoantibodies, although the ex- 
planation  for this  effect may be complex. 
We found that >90% of the DN ceils were eliminated in 
Ipr mice deficient in  ~82m expression.  In  a previous TCR 
repertoire analysis  of Ipr mice, we noted that  DN cells ex- 
pressed a V~/pattern resembling that of the CD8 + popula- 
tion (11). Furthermore, particular class I molecules influenced 
both DN  and  CD8 + VB repertoires  in  a similar  fashion. 
The present results extend these earlier studies and strongly 
support the hypothesis that  most of the DN population is 
selected and/or expanded on class I MHC. The close connec- 
tion of DN cells with the CD8 lineage is further supported 
by recent  studies (35)  showing that  anti-CD8  mAb treat- 
ment prevents the development of most DN cells. The findings 
are also consistent with the methylation pattern of the CD8 
gene in these cells,  reflecting previous expression (13). 
It seems likely that both intrathymic selection and periph- 
eral proliferation of most DN cells involve recognition of class 
I. Lymphoproliferation in lpr mice requires peripheral expan- 
sion of lymphocyte subsets. Thus,  thymectomy performed 
more than a few weeks after birth, and before the appearance 
of B220 + T cells, has little effect on the subsequent accumu- 
lation  of DN T  cells  (11, 16).  We previously showed that 
V/38.3 + T  cells are overrepresented in the DN population 
compared with the CD4 + or CD8 + subsets. Longitudinal 
studies and studies of thymectomized animals indicated that 
this subset of DN cells is selectively expanded in the periphery. 
In the present studies, the accumulation of DN V/38.3 + T 
ceils was also apparent  in 132m+lpr mice but was absent in 
[32m-lpr mice,  indicating  that  this  V/3-selective  increase is 
a class I-dependent phenomenon.  The nature of the class I 
MHC-antigen complex which interacts with V/38.3  is un- 
clear.  In preliminary  work (Kotzin,  B. L., V.  Kakkanaiah, 
E. Roper, P. Cohen, and R. Eisenberg, unpublished obser- 
vations),  the DN VB8.3 + cells  in Ipr mice have not been 
found to be oligoclonal and there have not been any repeated 
CDR3 motifs. The only similar V  region element  among 
these cells  therefore appears to be the V/3.  We do not yet 
understand this observation, because neither a class I-presented 
superantigen nor a V/38.3-selective  superantigen has yet been 
described. 
The  presence  of a residual  DN  population  in 132m-Ipr 
645  Maldonado  et al. mice prompted us to determine whether these cells were CD8- 
or CD4-1ike in their TCR repertoire.  32m-knockout mice 
may have detectable levels of class I,  most likely related to 
surface expression of small amounts of class I cr chain alone, 
and the few CD8 §  T  cells  they produce can be shown to 
proliferate in the periphery (36, 37). Therefore, it was pos- 
sible  that  the  remaining  DN  cells  in  32m-Ipr  mice  were 
selected on this unusual type of class I. However, our anal- 
ysis of V3 expression in DN cells  indicated a shift from a 
CD8-1ike pattern in control 32m + Ipr mice to a CD4-1ike V3 
pattern in 32m-Ipr mice. These results suggest that a rela- 
tively small component of DN cells in lpr mice has been selected 
on class II rather than class I MHC. The fact that this subset 
is <10% of the total DN population in liar mice may explain 
apparent  discrepancies with previous studies.  For example, 
our  previous  attempt  to  demonstrate  selection  of  DN 
V317 + cells on class II could have been obscured by oppo- 
site trends in the subset of V317 + cells selected on class I 
(11).  Similarly,  other  studies  showed little change in lym- 
phoproliferation  in class II knockout Ipr mice, but it seems 
unlikely that a <10% decrease of DN cells would have been 
detected by the methods used in these experiments  (38). 
It is of interest that Bix et al.  (39) also used 32m-  mice 
to show that the normal DN TCR oe/3 + thymocytes in B6 
mice are mostly selected on MHC class I.  Although  some 
characteristics of this thymic population  suggest a possible 
relationship  to peripheral Ipr DN T  cells,  major differences 
between these two DN T cell populations are apparent. Im- 
portantly, the thymic DN cells are strongly skewed towards 
VflS.2 expression, whereas the lpr DN show a more diverse 
V3 repertoire with a preferential use of V38.3.  The small 
peripheral DN T cell population present in non-lpr mice has 
also been proposed as a normal counterpart of Ipr DN T cells, 
but TCR V3 analysis  has demonstrated  a lack of evidence 
for intrathymic positive and negative selection that is charac- 
teristic  of Ipr DN T  cells (11, 40). 
Nearly all DN cells in Ipr mice express the oe/3 TCR (1). 
It is unclear whether a very small component of the aberrant 
T  cell population  may express 3'/8 TCR.  Interestingly,  in 
32m- Ipr mice, we noted a striking increase in the percentage 
and number of 3'/8 + T  cells. Compared with normal animals 
(41),  the  increase  in  3"/8 +  T  cells  in 32m-lpr  mice  was 
>100-fold, reflecting a 10-15-fold increase in percentage and 
a ninefold increase  in LN cell number.  Thus,  the lpr muta- 
tion may cause an expansion of the "1,/8  + T cell population, 
most likely because peripheral elimination of a subset of these 
cells  is prevented by decreased expression of f as.  Why the 
number of "1,/8 + T  cells was increased twofold in 32m-lpr 
compared  with  [32m+Ipr mice  remains  unclear,  especially 
since CD4 § cells did not increase  in a similar  fashion. 
IgG autoantibodies and total IgG levels, but not IgM au- 
toantibodies  or total  IgM levels were reduced in 32m-lpr 
mice. The patterns suggest that there was not a selective effect 
on autoantibody versus normal antibody population. These 
findings may also relate to previous studies of nonautoim- 
mune 32m-  mice in which antibody production to exoge- 
nous antigens and total IgG, but not total IgM, levels were 
similarly reduced (42).  These earlier studies have led to the 
hypothesis that  there is a role for class I in B cell develop- 
ment and/or in the B-T cell interactions necessary for efficient 
IgG antibody production (21).  Previous studies of lpr mice 
have shown the expected dependence of autoantibody produc- 
tion on CD4 + T cells and MHC class II expression (27, 38, 
43, 44). In the present  studies, it is possible but less likely 
that the absence of class I-dependent DN cells is responsible 
for the reduced autoantibody production  in these mice. 
Previous studies from our laboratories and others indicate 
that  positive  and  negative selection within  the  thymus  is 
mostly normal in lpr mice (10-12). Thus, intrathymic events 
appear to be independent of Fas, implying that another system 
mediating  apoptosis  must  be involved.  In  contrast,  other 
studies (17-20) suggest that peripheral tolerance mechanisms 
may be severely affected by the lpr mutation  and decreased 
expression of Fas. The present work supports the concept 
that all T  cell subsets, including CD4 +, CD8 +, and 3'/8 + 
cells, are influenced by the impairment of Fas-mediated apop- 
tosis, although  the effect on CD8 § cells appears to be the 
major factor in generating the DN population. Downregu- 
lation of accessory CD4 or CD8 molecules also appears  to 
be a consequence of a lesion in the Fas pathway (11). Despite 
evidence for some selectivity for particular TCR in the pe- 
ripheral expansion process, the heterogeneous repertoire of 
the DN  T  cells  indicates  that  many clones are  expanded. 
Whether these clones have an autoreactive potential remains 
a major question. 
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